Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
复制标题
DOI:
10.1186/s12879-020-05233-x
复制
发表时间:
2020-07-14
影响因子:
3.7
通讯作者:
Huang, Yuehua
中科院分区:
文献类型:
--
作者:
Gu, Yurong;Lian, Yifan;Huang, Yuehua
Background Complete clearance of intracellular viruses depends on effector cells of innate and adaptive immune systems. This study aimed to identify the relationships among antiviral cytokines produced by natural killer (NK) and T cells and clinical-virological characteristics in untreated chronic hepatitis B (CHB) patients. Methods We measured antiviral cytokines interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and interleukin-2 (IL-2) produced by T, NK and natural killer T (NKT) cells, respectively, in a cohort with chronic hepatitis B virus (HBV) infection (CHB). We also correlated these cytokines with clinical-virological characteristics using a linear regression model. Results levels of IFN-gamma(+)and TNF-alpha(+)CD4(+)and CD8(+)T cells were significantly higher in immune active (IA) phase than in other phases. Immune tolerant (IT) patients showed the lowest expression of IFN-gamma by NK and NKT cells, and TNF-alpha by NK cells. IFN-gamma(+), TNF-alpha(+)and IL-2(+)CD4(+)and CD8(+)T cells frequencies were similar between IA and gray zone (GZ) phases. Principal component analysis based on cytokines confirmed that most IT patients significantly differed from inactive carriers (IC) and IA patients, while GZ patients were widely scattered. Multivariate analysis showed both T and NK cells producing IFN-gamma and TNF-alpha, but not IL-2, had significant association with serum alanine aminotransferase (ALT). Moreover, IFN-gamma+NKT cells were associated with HBV DNA, while IFN-gamma(+)CD4(+)and CD8(+)T cells were correlated with age. Conclusion HBV clinical phases are characterized by distinct cytokine signatures, which showed relationship to viral features in these untreated CHB patients.